Both Hengrui Pharmas ribupatide and Innovents higher-dose mazdutide have reported phase 3 trial data suggesting greater weight-loss efficacy than semaglutide
At the same time, those findings come from structured studies with defined eligibility criteria, protocol-driven dose escalation, and formal safety monitoring
Prepare Your Medication List Create a complete list of all current medications, including prescription medications with doses and frequencies, over-the-counter medications, supplements and vitamins, and any recent medication changes
The clinical data arrived ahead of the regulatory infrastructure
Main side effects: Nausea, vomiting, loss of appetite, diarrhea, or constipation are equally likely to occur
But Wegovy has limited availability, and many patients and even some prescribers turn to Ozempic instead